Over 170 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
50 presentations, case studies and panel discussions focused on the key issues in cell line optimisation, process development and biological production
4 interactive streams:
Cell Line Development: Novel Tools and Techniques
Process Development: Upstream and Downstream Process Optimisation
Cell Line Development: Ensuring Stability and Quality of Cell Lines
Biological Production: Manufacturing and Cell Banking Case Studies
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities
Building on the success of last year’s event, Oxford Global Conferences are proud to present the 3rd Annual Cell Culture and Bioprocessing Congress, taking place on the 17th and 18th of November 2014 in London. This Congress is an executive platform for over 170 experts working in cell line development, cell line engineering, up and downstream operations, fermentation and biologics production.
A huge increase in global demand for biopharmaceutical products has increased the value of the cell culture industry significantly in the past few years; it is poised to reach a worth of over $6 billion by 2018. This Congress brings together leading experts to discuss ways to support this growth and overcome industry-wide challenges, and will be supported by key industry solution providers like Merck Millipore, Eppendorf, UPM, Solentim and Hamilton. Problems to be discussed include cell line stability, cell line authentication, scale-up improvements, contamination control and increasing reliability and consistency between batches.
On Day One, our panel of experts will discuss the latest advances in cell line and process development. Topics will include transfection of primary and hard-to-transfect cells, novel tools for 3D cell culture, new technologies for media optimization, high throughput cell culture techniques, achieving high titre cell cultures, disposable technology and automated cell line processes.
Day Two of the event will include case studies covering the most important challenges in biological production. Presentations will address how to develop commercially suitable cell banks, improve manufacturing flexibility, standardize single-use technology, ensure successful technology transfer and optimise cell lines for manufacturing. Our panel of industry leaders will also discuss key advances in cell line development, including the genetic characterisation of cell lines using NGS, cell line authentication technologies, contamination prevention methods and innovative cell culture assays.
The 3rd Annual Cell Culture & Bioprocessing Congress forms part of Oxford Global’s highly successful Biologics Series. Upcoming events in the series include:
8th Annual Proteins & Antibodies Congress, 2nd and 3rd of April 2015, London
www.proteins-congress.com
2nd Annual Peptides Congress, 2nd and 3rd of April 2015, London
www.peptides-congress.com
3rd Annual Biosimilars & Biobetters Congress, 2nd and 3rd of April 2015, London
www.biosimilars-congress.com
Agenda
The Event
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 40 speakers will present a full conference programme covering the topics outlined below.
Day 1 Stream 1
Cell Line Development
Transfection of primary and hard-to-transfect cells
Novel tools for 3D cell culture
New technologies for media optimization
Stem cell mixture purification
High-throughput cell culture techniques
Successful fermentation methods
Day 1 Stream 2
Process Development
Increasing the efficiency of upstream processes
Integrating upstream and downstream processing
Novel downstream processing platforms
High-titre cell culture processes
Process development case studies:
Scale-up improvements
Disposable bioreactors
Automated cell line processes
Day 2 Stream 1
Cell Line Development
Cell line characterisation using NGS
Cell line engineering for high expression levels
Cell line selection
Technologies for cell line authentication
Methods for preventing contamination
Techniques to improve the stability of cell lines
Advanced cell culture assays
Day 2 Stream 2
Biological Production
Bio-manufacturing case studies:
Gene therapies
Viral vaccines
Monoclonal antibodies
Developing commercially suitable cell banks
Improving manufacturing flexibility
Standardization of single-use technology
Ensuring successful technology transfer and process validation
Optimizing cell lines for manufacturing
Agenda
The Event
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 40 speakers will present a full conference programme covering the topics outlined below.
Day 1 Stream 1
Cell Line Development
Transfection of primary and hard-to-transfect cells
Novel tools for 3D cell culture
New technologies for media optimization
Stem cell mixture purification
High-throughput cell culture techniques
Successful fermentation methods
Day 1 Stream 2
Process Development
Increasing the efficiency of upstream processes
Integrating upstream and downstream processing
Novel downstream processing platforms
High-titre cell culture processes
Process development case studies:
Scale-up improvements
Disposable bioreactors
Automated cell line processes
Day 2 Stream 1
Cell Line Development
Cell line characterisation using NGS
Cell line engineering for high expression levels
Cell line selection
Technologies for cell line authentication
Methods for preventing contamination
Techniques to improve the stability of cell lines
Advanced cell culture assays
Day 2 Stream 2
Biological Production
Bio-manufacturing case studies:
Gene therapies
Viral vaccines
Monoclonal antibodies
Developing commercially suitable cell banks
Improving manufacturing flexibility
Standardization of single-use technology
Ensuring successful technology transfer and process validation
Optimizing cell lines for manufacturing
Who will attend
The Cell Culture & Bioprocessing Congress is an exclusive event designed for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions. Delegates typically include VPs, Directors and Global Heads of:
-
Analytical Biochemistry
-
Bacterial Fermentation
-
Biological Process
Development
-
Bioprocessing
-
Cell Biology
-
Cell Culture
-
Cell Line Selection
-
Cell Line Engineering
-
CMC Biologics
|
-
CMO Liaison
-
Downstream Processing
-
Manufacturing
-
Medium Development
-
Metabolic Profiling
-
Molecular Cell biology
-
Process Engineering
-
Process Science
-
Technical Development
-
Upstream Processing
|
|
|
|
Delegates will benefit from:
-
An executive format providing intimate interaction with industry peers’ ideas and experiences through case study presentations and panel discussions
-
Networking opportunities and sharing ideas with other senior peers
-
Pre-scheduled one-to-one meetings between you and solution providers will provide you with an opportunity to forge partnerships and discover solutions
-
Post event follow up offering all documentation from the meeting and re-booking discounts
-
Tailor-made agenda – hand pick any conference and panel sessions you wish to attend
Who is speaking
Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.
If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Jennifer Clark at j.clark@oxfordglobal.co.uk
2014 Speakers
-
Cécile Bauche
CSO, Theravectys
-
Matthew Beard
Senior Principle Scientist, Ipsen
-
Valentina Ciccarone
Principal Scientist, Macrogenics
-
Ciska Dalm
Lead Scientist, Synthon
-
David Danovi
Director, HipSci Cell Phenotyping, Centre for Stem Cells and Regenerative Medicine, King's College London
-
Patrik Froech
Head of Molecular Biology and Gene Expression, UCB
-
John Harrington
Executive Vice President and Chief Scientific Officer, Athersys
-
Philip Hass
Senior Scientific Manager, Genentech
-
Chris Hewitt
Professor of Biological Engineering, Director of the DTC in Regenerative Medicine, Loughborough University
-
Dave Knop
Director, Process Development, Applied Genetics Technology Corporation.
-
Hans-Peter Knopf
Senior Biologics Expert, Novartis
-
Luc Kupers
Program Manager Global Cell Cuture Media Strategy, Genzyme, a Sanofi company
-
Holger Laux
Fellow, Novartis
-
Edith Lecomte-Norrant
Innovation Technology Sciences Director, UCB Biopharma
-
Nicolas Mermod
Professor, University of Lausanne
-
Lisa Milano
Global Quality Systems, Supply Chain, Genentech
-
Peter Mooney
Medical Scientific Liaison Manager Europe, Sanofi Biosurgery
-
Christiane Niederlaender
Quality Assessor, Biologicals, MHRA
-
Alvin Nienow
Emeritus Professor of Biochemical Engineering, University of Birmingham
-
Anne Ramne
Senior Research Scientist, AstraZeneca
-
Ulrich Ruemenapp
Head of Biotechnology Projects, Bayer
-
Manfred Schuster
COO, Apeiron Biologics
-
Maurice van der Heijden
Director R&D, ProteoNic
-
Lance Wong
Director, Process Development, Bavarian Nordic
-
Jianxin Ye
Principal Scientist, Merck